Exact Mass: 411.2310504
Exact Mass Matches: 411.2310504
Found 427 metabolites which its exact mass value is equals to given mass value 411.2310504,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fluvastatin
C24H26FNO4 (411.18457680000006)
Fluvastatin is an antilipemic agent that competitively inhibits hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reducuase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Fluvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].
Acetophenazine
C23H29N3O2S (411.19803740000003)
Acetophenazine is only found in individuals that have used or taken this drug.It is an antipsychotic drug of moderate-potency. It is used in the treatment of disorganized and psychotic thinking. It is also used to help treat false perceptions (e.g. hallucinations or delusions).Acetophenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Lasiocarpine
C21H33NO7 (411.22569080000005)
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2259 Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids
Etorphine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics Same as: D07937
LysoPC(10:0/0:0)
C18H38NO7P (411.23857680000003)
LysoPC(10:0/0:0) is a lysophosphatidylcholine, which is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2 as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. There is also a phospholipase A1, which is able to cleave the sn-1 ester bond. Lysophosphatidylcholine has pro-inflammatory properties in vitro and it is known to be a pathological component of oxidized lipoproteins (LDL) in plasma and of atherosclerotic lesions. Recently, it has been found to have some functions in cell signalling, and specific receptors (coupled to G proteins) have been identified. It activates the specific phospholipase C that releases diacylglycerols and inositol triphosphate with resultant increases in intracellular Ca2+ and activation of protein kinase C. It also activates the mitogen-activated protein kinase in certain cell types. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPC(10:0/0:0), in particular, consists of one chain of capric acid at the C-1 position. 1-Decanoyllysolecithin is a glycerophosphocholine. Glycerophosphocholines are a class of glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the SN-1 and SN-2 positions. fatty acids containing 16, 18 and 20 carbons are the most common. (LipidMAPS) [HMDB]
Carphenazine
C23H29N3O2S (411.19803740000003)
Carphenazine is only found in individuals that have used or taken this drug. It is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term "phenothiazines" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.
Fesoterodine
C26H37NO3 (411.27732920000005)
Fesoterodine is only found in individuals that have used or taken this drug. It is an antimuscarinic prodrug used for treating overactive bladder syndrome.Fesoterodine, once converted to its active metabolite, 5-hydroxymethyltolterodine, acts as a competitive antagonists at muscarinic receptors. This results in the inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents
N-Linoleoyl Methionine
C23H41NO3S (411.28069960000005)
N-linoleoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Etorphine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
1,2-Dihexanoyl-sn-glycero-3-phosphoethanolamine
1-(2-(4-(3-Phenyl-2H-1-benzopyran-2-yl)phenoxy)ethyl)piperidine
(3S,5R)-7-[3-(4-Fluorophenyl)-1-propan-2-yl-2-indolyl]-3,5-dihydroxy-6-heptenoic acid
C24H26FNO4 (411.18457680000006)
2-Amino-1-[2-(4-fluorophenyl)-3-[(4-fluorophenyl)amino]-5,6-dihydro-8,8-dimethylimidazo[1,2-a]pyrazin-7(8H)-yl]ethanone
C22H23F2N5O (411.18705719999997)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Piroxantrone
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
Sacubitril
C24H29NO5 (411.20456240000004)
Teloxantrone
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
dysolenticin J
C26H37NO3 (411.27732920000005)
A natural product found in Dysoxylum lenticellatum.
9-[2-amino-3-(4'-O-methyl-alpha-ribopyranosyloxy)phenyl]nonanoic acid
C21H33NO7 (411.22569080000005)
Brachystamide C|brachystamide-C|N-isobutyl-15-(3,4-methylenedioxyphenyl)-2E,4E,13E-pentadecatrienamide
C26H37NO3 (411.27732920000005)
Lasiocarpine
C21H33NO7 (411.22569080000005)
Lasiocarpine appears as colorless plates or beige crystalline solid. (NTP, 1992) Lasiocarpine is a natural product found in Heliotropium arbainense, Heliotropium suaveolens, and other organisms with data available. See also: Comfrey Leaf (part of); Comfrey Root (part of).
Lescol
C24H26FNO4 (411.18457680000006)
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors CONFIDENCE standard compound; INTERNAL_ID 2102 Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].
fluvastatin
C24H26FNO4 (411.18457680000006)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3136 Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].
ACETOPHENAZINE
C23H29N3O2S (411.19803740000003)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
1-Decanoyl-2-hydroxy-sn-glycero-3-phosphocholine
C18H38NO7P (411.23857680000003)
(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide
C26H37NO3 (411.27732920000005)
C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)
C23H29N3O4 (411.21579540000005)
(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide [IIN-based on: CCMSLIB00000848860]
C26H37NO3 (411.27732920000005)
(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide [IIN-based: Match]
C26H37NO3 (411.27732920000005)
1-decanoyl-sn-glycero-3-phosphocholine
C18H38NO7P (411.23857680000003)
A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as capryl (decanoyl).
Ala Ala His Asn
Ala Ala Asn His
Ala Gly His Lys
C17H29N7O5 (411.22300640000003)
Ala Gly His Gln
Ala Gly Lys His
C17H29N7O5 (411.22300640000003)
Ala Gly Gln His
Ala His Ala Asn
Ala His Gly Lys
C17H29N7O5 (411.22300640000003)
Ala His Gly Gln
Ala His Lys Gly
C17H29N7O5 (411.22300640000003)
Ala His Asn Ala
Ala His Gln Gly
Ala Lys Gly His
C17H29N7O5 (411.22300640000003)
Ala Lys His Gly
C17H29N7O5 (411.22300640000003)
Ala Lys Pro Pro
C19H33N5O5 (411.24815680000006)
Ala Asn Ala His
Ala Asn His Ala
Ala Pro Lys Pro
C19H33N5O5 (411.24815680000006)
Ala Pro Pro Lys
C19H33N5O5 (411.24815680000006)
Ala Pro Pro Gln
Ala Pro Gln Pro
Ala Gln Gly His
Ala Gln His Gly
Ala Gln Pro Pro
Gly Ala His Lys
C17H29N7O5 (411.22300640000003)
Gly Ala His Gln
Gly Ala Lys His
C17H29N7O5 (411.22300640000003)
Gly Ala Gln His
Gly His Ala Lys
C17H29N7O5 (411.22300640000003)
Gly His Ala Gln
Gly His Lys Ala
C17H29N7O5 (411.22300640000003)
Gly His Gln Ala
Gly Lys Ala His
C17H29N7O5 (411.22300640000003)
Gly Lys His Ala
C17H29N7O5 (411.22300640000003)
Gly Gln Ala His
Gly Gln His Ala
His Ala Ala Asn
His Ala Gly Lys
C17H29N7O5 (411.22300640000003)
His Ala Gly Gln
His Ala Lys Gly
C17H29N7O5 (411.22300640000003)
His Ala Asn Ala
His Ala Gln Gly
His Gly Ala Lys
C17H29N7O5 (411.22300640000003)
His Gly Ala Gln
His Gly Lys Ala
C17H29N7O5 (411.22300640000003)
His Gly Gln Ala
His Lys Ala Gly
C17H29N7O5 (411.22300640000003)
His Lys Gly Ala
C17H29N7O5 (411.22300640000003)
His Asn Ala Ala
His Gln Ala Gly
His Gln Gly Ala
Lys Ala Gly His
C17H29N7O5 (411.22300640000003)
Lys Ala His Gly
C17H29N7O5 (411.22300640000003)
Lys Ala Pro Pro
C19H33N5O5 (411.24815680000006)
Lys Gly Ala His
C17H29N7O5 (411.22300640000003)
Lys Gly His Ala
C17H29N7O5 (411.22300640000003)
Lys His Ala Gly
C17H29N7O5 (411.22300640000003)
Lys His Gly Ala
C17H29N7O5 (411.22300640000003)
Lys Pro Ala Pro
C19H33N5O5 (411.24815680000006)
Lys Pro Pro Ala
C19H33N5O5 (411.24815680000006)
Asn Ala Ala His
Asn Ala His Ala
Asn His Ala Ala
Pro Ala Lys Pro
C19H33N5O5 (411.24815680000006)
Pro Ala Pro Lys
C19H33N5O5 (411.24815680000006)
Pro Ala Pro Gln
Pro Ala Gln Pro
Pro Lys Ala Pro
C19H33N5O5 (411.24815680000006)
Pro Lys Pro Ala
C19H33N5O5 (411.24815680000006)
Pro Pro Ala Lys
C19H33N5O5 (411.24815680000006)
Pro Pro Ala Gln
Pro Pro Lys Ala
C19H33N5O5 (411.24815680000006)
Pro Pro Gln Ala
Pro Gln Ala Pro
Pro Gln Pro Ala
Gln Ala Gly His
Gln Ala His Gly
Gln Ala Pro Pro
Gln Gly Ala His
Gln Gly His Ala
Gln His Ala Gly
Gln His Gly Ala
Gln Pro Ala Pro
Gln Pro Pro Ala
Platelet-activating factor
C18H38NO7P (411.23857680000003)
1-Decanoyllysolecithin
C18H38NO7P (411.23857680000003)
Decanoyllysophosphatidylcholine
C18H38NO7P (411.23857680000003)
PC(0:0/10:0)[U]
C18H38NO7P (411.23857680000003)
PE(6:0/6:0)
Piriprost
Carphenazine
C23H29N3O2S (411.19803740000003)
Fesoterodine
C26H37NO3 (411.27732920000005)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents
NA 26:8;O
C26H37NO3 (411.27732920000005)
3-N-BOC-AMINO-1-[2-AMINO-1-(4-BENZYLOXY-PHENYL)-ETHYL]-PYRROLIDINE
4-(Dicyanomethylene)-2-methyl-6-(1,1,7,7-tetramethyljulolidyl-9-enyl)-4H-pyran
sacubitril
C24H29NO5 (411.20456240000004)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent
1-[12-(4-ethylphenyl)dodecoxy]-2-nitrobenzene
C26H37NO3 (411.27732920000005)
3-Amino-4-chlorobenzoic acid 2-dodecyloxy-1-methyl-2-oxoethyl ester
C22H34ClNO4 (411.2176234000001)
2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid
C24H29NO5 (411.20456240000004)
1-(2-ethylhexyl)-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile
Balicatib
C23H33N5O2 (411.26341180000003)
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor C471 - Enzyme Inhibitor
1,3,3-Trimethylindolino-6-(1-piperidinyl)spironaphthoxazine
(2R,4S)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoate
Phenol,2-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-Methoxy
(R)-3-[1-(4-Fluoro-benzyl)-1H-benzoiMidazol-2-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester
(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4-oxobutanamido)-2-methylbutanoic acid
C24H29NO5 (411.20456240000004)
(2R,3S)-O,O-DIACETYL-3-DIBENZYLAMINO-5-METHYLHEXANE-1,2-DIOL
Nalmefene hydrochloride dihydrate
C21H30ClNO5 (411.18124000000006)
Fluvastatin sodium anti-isomer free acid
C24H26FNO4 (411.18457680000006)
rac N,N-Didesmethyl-O-desmethyl Venlafaxine Glucuronide
1-O-Decylpropanediyl-3-phosphorylcholine
C18H38NO7P (411.23857680000003)
(4Z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline
1-[10-[3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-3-yl]ethanone
C23H29N3O2S (411.19803740000003)
(2R,3R,4S,7S)-3-[(3R,4R)-3,4-dihydroxypentanoyl]oxy-7-(3-hydroxyphenyl)-7-methoxy-2,4-dimethylheptanoate
D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
C24H26FNO4 (411.18457680000006)
2-azaniumylethyl (2R)-2,3-bis(hexanoyloxy)propyl phosphate
2,11-Dimethoxy-9-(2-methylbut-3-en-2-yl)-14-propan-2-yl-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
C23H29N3O4 (411.21579540000005)
(3R)-3-(2-fluoro-5-methylphenyl)-7-phenyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
1-Phenyl-4-[[1-(phenylmethyl)-5-tetrazolyl]-(3-pyridinyl)methyl]piperazine
2-[4-[(6-Ethoxy-2-quinolinyl)methyl]-1-(3-thiophenylmethyl)-2-piperazinyl]ethanol
C23H29N3O2S (411.19803740000003)
N,N-(6-((4-(hydroxy(phenyl)methyl)phenyl)amino)-6-oxohexane-1,5-diyl)diacetamide
C23H29N3O4 (411.21579540000005)
[2-(2-Methoxyethyl)-1-piperidinyl]-[5-[[4-(1,2,4-triazol-1-yl)phenoxy]methyl]-3-isoxazolyl]methanone
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
N-tert-butyl-2-(4-tert-butyl-N-(2-methoxy-1-oxoethyl)anilino)-2-(3-pyridinyl)acetamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester
C19H33N5O5 (411.24815680000006)
(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-1-(cyclopropanecarbonyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C23H29N3O4 (411.21579540000005)
(1S,9R,10R,11R)-N-cyclobutyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
2-[(2S,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2R,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2R,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[cyclopropyl(oxo)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C23H29N3O4 (411.21579540000005)
(1R,9S,10S,11S)-N-cyclobutyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(6S,7S,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
2-(dimethylamino)-1-[(2S,3R)-6-[(4-fluorophenyl)-oxomethyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
2-[(2R,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2S,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2S,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2S,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2R,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(dimethylamino)propyl]acetamide
C19H29N3O5S (411.18278240000006)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C23H29N3O4 (411.21579540000005)
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C19H33N5O5 (411.24815680000006)
(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-1-(cyclopropylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3R)-1-acetyl-N-cyclohexyl-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide
(2S,3S)-1-acetyl-N-cyclohexyl-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide
1-[(2R,3R)-6-(cyclobutanecarbonyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
1-[(2S,3R)-6-(cyclobutanecarbonyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
1-[(2S,3S)-6-(cyclobutanecarbonyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
(6S,7R,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
1-ethyl-2-[5-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dien-1-yl]-3,3-dimethyl-3H-indolium
N-[(2S)-1-oxo-1-[[(2S)-1-oxo-1-[2-(2,4,5-trihydroxyphenyl)ethylamino]propan-2-yl]amino]propan-2-yl]carbamic acid tert-butyl ester
(2-Hydroxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C19H42NO6P (411.27496020000007)
2-Aminoethyl (2-hydroxy-3-tetradecoxypropyl) hydrogen phosphate
C19H42NO6P (411.27496020000007)
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tridecanoate
C18H38NO7P (411.23857680000003)
(2-Acetyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C18H38NO7P (411.23857680000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] pentanoate
C18H38NO7P (411.23857680000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] butanoate
C18H38NO7P (411.23857680000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] acetate
C18H38NO7P (411.23857680000003)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] propanoate
C18H38NO7P (411.23857680000003)
(3-Acetyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Hexanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] heptanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] octanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] nonanoate
(3-Butanoyloxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate
2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium
C18H40N2O6P+ (411.26238500000005)
2-[(2-Acetamido-3-hydroxyundecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C18H40N2O6P+ (411.26238500000005)
2-[Hydroxy-[3-hydroxy-2-(propanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium
C18H40N2O6P+ (411.26238500000005)
2-[[2-(Butanoylamino)-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C18H40N2O6P+ (411.26238500000005)
1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one
C23H29N3O2S (411.19803740000003)
1-tridecanoyl-sn-glycero-3-phosphoethanolamine
C18H38NO7P (411.23857680000003)
N-arachidonoyltaurine
C22H37NO4S (411.24431620000007)
A fatty acid-taurine conjugate derived from arachidonic acid.
19-O-acetylhoerhammericine(1+)
An ammonium ion derivative resulting from the protonation of the tertiary amino group of 19-O-acetylhoerhammericine. The major species at pH 7.3. Note the stereoconfiguration of the epoxy group is based on CHEBI:144374, and of the 19-acetoxy group on CHEBI:144372.
17alpha-hydroxypregnenolone 3-sulfate(1-)
A steroid sulfate oxoanion obtained by deprotonation of the sulfo group of 17alpha-hydroxypregnenolone 3-sulfate.
MK-6884
MK-6884 is a M4 muscarinic receptor positive allosteric modulator (PAM) with a Ki value of 0.19 nM. MK-6884 can be used for the research of the neurodegenerative diseases. MK-6884 can be conveniently radiolabeled with carbon-11 and as a positron emission tomography (PET) imaging agent[1].
n-[(3s,6r)-6-{[(2s,3s,4r,5s)-1,4-diamino-2,5,6-trihydroxyhexan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]butanimidic acid
(1s,7ar)-7-({[(2s)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
C21H33NO7 (411.22569080000005)
12-hydroxy-n-{2,9,10-trihydroxy-6-oxo-1-oxaspiro[4.5]dec-7-en-3-yl}dodec-2-enimidic acid
C21H33NO7 (411.22569080000005)
(3s)-6-methyl-3-[(6r)-6-[(2-methyl-4-oxohexan-3-yl)-c-hydroxycarbonimidoyl]-1,2-diazinane-1-carbonyl]heptanoic acid
C21H37N3O5 (411.27330720000003)
(1s,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
C21H33NO7 (411.22569080000005)
(7ar)-7-({[(2r)-2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate
C21H33NO7 (411.22569080000005)
15-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)pentadeca-2,4,14-trienimidic acid
C26H37NO3 (411.27732920000005)
(2e)-12-hydroxy-n-[(2r,3s,5s)-2,9,10-trihydroxy-6-oxo-1-oxaspiro[4.5]dec-7-en-3-yl]dodec-2-enimidic acid
C21H33NO7 (411.22569080000005)
(1s,3r,6r,7z,9e,13s,15r,16r)-13-methoxy-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-azatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadeca-7,9,11-triene-11,15-diol
C26H37NO3 (411.27732920000005)
(8as)-6,7-bis(3,4-dimethoxyphenyl)-2,3,5,8-tetrahydro-1h-indolizin-8a-ol
C24H29NO5 (411.20456240000004)
(2e,4e,12e)-15-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]pentadeca-2,4,12-trienimidic acid
C26H37NO3 (411.27732920000005)
6,7-bis(3,4-dimethoxyphenyl)-2,3,5,8-tetrahydro-1h-indolizin-8a-ol
C24H29NO5 (411.20456240000004)
(2e)-12-hydroxy-n-[(1s,2s,4s,5s,6r,7r,8s)-1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl]dodec-2-enimidic acid
C21H33NO7 (411.22569080000005)
6-methyl-3-{6-[(2-methyl-4-oxohexan-3-yl)-c-hydroxycarbonimidoyl]-1,2-diazinane-1-carbonyl}heptanoic acid
C21H37N3O5 (411.27330720000003)
10-{1,4-dimethyl-2,8-dioxabicyclo[3.2.1]octan-3-yl}-7,9-dihydroxy-2-(hydroxymethyl)-6,8-dimethylundeca-2,4-dienimidic acid
C22H37NO6 (411.26207420000003)
6-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-8-oxa-4-azatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6-tetraene-5,10,11-triol
C24H29NO5 (411.20456240000004)
(10r,11r)-6-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-8-oxa-4-azatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6-tetraene-5,10,11-triol
C24H29NO5 (411.20456240000004)
(1s,2r)-1-hydroxy-2-[(2s,5e)-2-hydroxy-6,10-dimethylundeca-5,9-dien-2-yl]-4-methyl-1h,2h-furo[2,3-c]quinolin-5-ium-5-olate
15-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)pentadeca-2,4,13-trienimidic acid
C26H37NO3 (411.27732920000005)
(3s,3as,7s,7ar)-3-benzyl-7-[(4s,5s,6s)-5,6-dihydroxy-4-methylhept-1-en-1-yl]-5-methyl-4-methylidene-3a,7-dihydro-3h-isoindole-1,7a-diol
3-[(1r,3as,5as,7r,9ar,9br,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-hydroxypyrrol-2-one
C26H37NO3 (411.27732920000005)
(2e)-12-hydroxy-n-[(1s,2s,4s,5s,6s,7s,8s)-1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl]dodec-2-enimidic acid
C21H33NO7 (411.22569080000005)
1-hydroxy-2-(2-hydroxy-6,10-dimethylundeca-5,9-dien-2-yl)-4-methyl-1h,2h-furo[2,3-c]quinolin-5-ium-5-olate
(5s)-5-(6-aminopurin-9-yl)-1-(4-hydroxy-3-methoxyphenyl)decan-3-one
6-hydroxy-16-(methoxymethyl)-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
(2e,4e,13e)-15-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)pentadeca-2,4,13-trienimidic acid
C26H37NO3 (411.27732920000005)
(1s,7ar)-7-({[(2s)-2,3-dihydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
C21H33NO7 (411.22569080000005)
(2z,4e,6s,7s,8r,9r,10r)-10-[(3s,4r,5s)-1,4-dimethyl-2,8-dioxabicyclo[3.2.1]octan-3-yl]-7,9-dihydroxy-2-(hydroxymethyl)-6,8-dimethylundeca-2,4-dienimidic acid
C22H37NO6 (411.26207420000003)
(2z,4e,6s,7s,8r,9r,10r)-10-[(1s,3s,4r,5s)-1,4-dimethyl-2,8-dioxabicyclo[3.2.1]octan-3-yl]-7,9-dihydroxy-2-(hydroxymethyl)-6,8-dimethylundeca-2,4-dienimidic acid
C22H37NO6 (411.26207420000003)
(1s,5r,8r,9s,10s,11r,14r,16s,17s,18r,19r)-19-hydroxy-5-methyl-12-methylidene-4-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl (2s)-2-methylbutanoate
(2e,4e,14e)-15-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]pentadeca-2,4,14-trienimidic acid
C26H37NO3 (411.27732920000005)
(2z,4e,6s,7s,8r,9r,10r)-10-[(1s,3s,4r,5r)-1,4-dimethyl-2,8-dioxabicyclo[3.2.1]octan-3-yl]-7,9-dihydroxy-2-(hydroxymethyl)-6,8-dimethylundeca-2,4-dienimidic acid
C22H37NO6 (411.26207420000003)
(2r,3r,4s,5s,6r)-1-butyl-2-(hydroxymethyl)-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)piperidine-3,4,5-triol
(2e,4e,12e)-15-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)pentadeca-2,4,12-trienimidic acid
C26H37NO3 (411.27732920000005)
9-{2-amino-3-[(3,4-dihydroxy-5-methoxyoxan-2-yl)oxy]phenyl}nonanoic acid
C21H33NO7 (411.22569080000005)
2-[(1-hydroxy-2-{[1-hydroxy-2-(methylamino)-3-phenylpropylidene]amino}-4-methylpentylidene)amino]benzoic acid
C23H29N3O4 (411.21579540000005)
(1s,6r,7s,7ar)-1-benzyl-4-[(4s,5s,6s)-5,6-dihydroxy-4-methylhept-1-en-1-yl]-3-hydroxy-6,7-dimethyl-1,6,7,7a-tetrahydroisoindol-5-one
(2e,4e,14e)-15-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)pentadeca-2,4,14-trienimidic acid
C26H37NO3 (411.27732920000005)
12-hydroxy-n-{1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl}dodec-2-enimidic acid
C21H33NO7 (411.22569080000005)
(1r,4s,5s,9r,12r,13s,14r,15s,16s,17r)-16-hydroxy-9-methyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-19-methylidene-11-azahexacyclo[12.3.2.0¹,¹³.0⁴,⁹.0⁵,¹².0⁵,¹⁷]nonadec-10-en-11-ium-11-olate
7-({[2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate
C21H33NO7 (411.22569080000005)
(1s,4s,7s,9r)-6-hydroxy-16-(methoxymethyl)-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
19-hydroxy-5-methyl-12-methylidene-4-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl 2-methylbutanoate
2-{[(2s)-1-hydroxy-2-{[(2r)-1-hydroxy-2-(methylamino)-3-phenylpropylidene]amino}-4-methylpentylidene]amino}benzoic acid
C23H29N3O4 (411.21579540000005)
4-{5-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4,6-dihydroxypyridin-3-yl}-4-hydroxycyclohex-2-en-1-one
C24H29NO5 (411.20456240000004)
15-hydroxy-13-methoxy-3,15-dimethyl-6-(6-methylhepta-3,5-dien-2-yl)-12-azatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadeca-7,9-dien-11-one
C26H37NO3 (411.27732920000005)
15-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)pentadeca-2,4,12-trienimidic acid
C26H37NO3 (411.27732920000005)
4-[5-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-4,6-dihydroxypyridin-3-yl]-4-hydroxycyclohex-2-en-1-one
C24H29NO5 (411.20456240000004)